Home

PAUL J SEKHRI

CIK 1264519 · Pres, CEO and Exec Chairperson · last filed 2026-08-03

PAUL J SEKHRI is a Pres, CEO and Exec Chairperson who has filed 94 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for APMD, was dated Aug 3, 2026. Across all open-market trades the lifetime net is −$8.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.68M

Companies

9

Total Filings

94

Lifetime Open-Market Net

-$8.05M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
APMD Director 12,500 — — $200.0K 1 2026-08-03
VEEV Director 15,191 $230.47 $3.50M -$8.39M 71 2026-06-22
VTVT Pres, CEO and Exec Chairperson 5,000 $35.37 $176.8K $83.8K 4 2026-02-18
Longboard Pharmaceuticals, Inc. (LBPH) Delisted Director — $59.98 — $0 4 2024-12-02
Axcella Health Inc. (AXLA) Delisted Director — $0.40 — $0 1 2022-05-25
BiomX Inc. (PHGE.WS) Delisted Director 12,500 $0.01 $110 $50.0K 3 2021-07-30
ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted Director — $64.97 — $0 3 2020-01-06
ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted Director — — — $0 1 2016-09-14
ARYx Therapeutics, Inc. (ARYX) Delisted Director — — — $0 3 2010-05-03

Recent Filings

94 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-03 APMD Mixed +12,500 $200.0K EDGAR
2026-06-22 VEEV Grant (A) — $0 EDGAR
2026-06-03 VEEV Exer (M) +253 $0 EDGAR
2026-03-03 VEEV Exer (M) +253 $0 EDGAR
2026-02-18 VTVT Grant (A) — $0 EDGAR
2025-12-03 VEEV Mixed −2,237 $0 EDGAR
2025-09-03 VEEV Exer (M) +253 $0 EDGAR
2025-06-20 VEEV Grant (A) — $0 EDGAR
2025-06-02 VEEV Exer (M) +329 $0 EDGAR
2025-03-07 VTVT Grant (A) — $0 EDGAR
Showing 1–10 of 94
Page 1 of 10
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.